28-day all-cause mortality in patients with alcoholic cirrhosis: a machine learning prediction model based on the MIMIC-IV.

Journal: Clinical and experimental medicine
Published Date:

Abstract

To develop and validate a machine learning prediction model for 28-day all-cause mortality in patients with alcoholic cirrhosis using data from the MIMIC-IV database. The data of 2134 patients diagnosed with alcoholic cirrhosis (AC) were obtained from Medical Information Mart for Intensive Care IV database. Machine learning algorithms, including decision trees, random forests, extreme gradient boosting, Logistic Regression and support vector machines were employed to develop the prediction model. The model was trained on 70% of the data and validated on the remaining 30% randomly. Performance was assessed using the area under the receiver operating characteristic curve, calibration curves and decision curve analysis (DCA). SHAP analysis was used to assess the marginal effects of each independent variable. The mean age was 56.2 years, and 69.5% were male. The primary factors associated with 28-day mortality included Age, SOFA score, ASPIII score, OASIS score, LODS score, Temperature, Chloride, Lactate, Total bilirubin (Tbil), international normalized ratio (INR), Activated partial thromboplastin time (Aptt), Stroke, Malignancy, Congenital coagulation defect (Ccd). The machine learning model demonstrated good predictive performance in the training and validation group, higher than traditional MELD score. Our machine learning prediction model effectively identifies patients with alcoholic cirrhosis at high risk of 28-day mortality. This model could assist clinicians in early risk stratification and guide clinical decision-making. Further validation in external cohorts is warranted to confirm its generalizability.

Authors

  • Chuang Lei
    Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
  • Zhixiang Ding
    Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
  • Qinghai Wang
    Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
  • Shanqing Tao
    Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
  • Qin Zhou
    The Affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China.
  • Pengfei Yin
    University of Florida, Gainesville, Florida, USA.
  • Yanhong Luo
    Hunan Children's Hospital, Changsha 410000, China.
  • Fan Yang
    School of Electrical Engineering and Automation, Jiangsu Normal University, Xuzhou, China.
  • Xingtong Chen
    Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
  • Yang Cai
  • Hainan Gong
    Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
  • Dehui Li
    Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China. lidehui0736@163.com.
  • Hao Li
    Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.